Our Pipeline
Pipeline Overview
The global clinical pipeline reflects a hematology/oncology focus with candidates across a range of indications in development. Through innovative science, we intend to expand into other areas where our technology can improve outcomes and address the unmet medical needs in myeloproliferative neoplasms.
This site and all materials are intended for US healthcare professionals as a nonpromotional resource for medical and scientific information and noncertified medical education purposes only.
- PharmaEssentia USA Corporation
- 35 Corporate Drive, Suite 325,
- Burlington, MA 01803, USA
- © 2023 PharmaEssentia Corporation. All rights reserved.
- PharmaEssentia and the PharmaEssentia logo are trademarks or registered trademarks of PharmaEssentia Corporation.
- MED-US-RPEG-2200019 (v1.0) 06/2023
You are now leaving this site and being directed to a site not maintained by PharmaEssentia.
PharmaEssentia is not responsible for content or privacy policies on other sites.